Northeast Financial Consultants Inc Precigen, Inc. Transaction History

Northeast Financial Consultants Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$1.41 - $2.79 $70,500 - $139,500	-50,000 Reduced 23.34%	164,209 $348,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $1.03 Million - $1.36 Million	165,454 Added 339.36%	214,209 $1.4 Million
Q2 2020 Jul 30, 2020	BUY	$2.16 - $5.46 $17,007 - $42,992	7,874 Added 19.26%	48,755 $243,000
Q1 2020 May 13, 2020	BUY	$1.46 - $7.19 $59,686 - $293,934	40,881 New	40,881 $139,000

141

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $264M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.